BPG is committed to discovery and dissemination of knowledge
Articles in Press
11/19/2026 12:17:55 PM | Browse: 16 | Download: 1
| Category |
Oncology |
| Manuscript Type |
Minireviews |
| Article Title |
Genotoxic therapy in children with Li-Fraumeni syndrome: Cure, risk, and management
|
| Manuscript Source |
Invited Manuscript |
| All Author List |
Mariangela Ruggiero and Antonio Ruggiero |
| Funding Agency and Grant Number |
|
| Corresponding Author |
Antonio Ruggiero, Associate Professor, MD, Department of Pediatrics, Department of Pediatrics, Universita’ Cattolica Sacro Cuore, Fondazione Policlinico Universitario Gemelli IRCCS, Largo F. Vito 1, Rome 00168, Italy. antonio.ruggiero@unicatt.it |
| Key Words |
Li-Fraumeni syndrome; TP53; Pediatric oncology; Genotoxic therapy; Radiotherapy; Second primary neoplasm; Cancer surveillance; Adrenocortical carcinoma |
| Core Tip |
The risk of a second cancer in Li-Fraumeni syndrome tends to be higher among those whose first cancer was diagnosed during childhood. This indicates that treatment choices in children have different implications compared to adults. Radiotherapy, based on pediatric data, has been shown to shorten the period until a second malignancy. Meanwhile, standard genotoxic chemotherapy for adrenocortical carcinoma and medulloblastoma in TP53 carriers has not been demonstrated to worsen outcomes though follow-up is still limited. Apart from CD19-directed chimeric antigen receptor T-cell therapy for B-cell leukemia, all other non-genotoxic alternatives are mostly unvalidated in children. Oncological treatment should be paired with structured surveillance and genetic counseling. |
| Citation |
Ruggiero M, Ruggiero A. Genotoxic therapy in children with Li-Fraumeni syndrome: Cure, risk, and management. World J Clin Pediatr 2026; In press
|
| PDF |
126807-in-press.pdf
|
 |
Received |
|
2026-08-14 08:12 |
 |
Peer-Review Started |
|
2026-08-14 08:12 |
 |
First Decision by Editorial Office Director |
|
|
 |
Return for Revision |
|
2026-09-14 03:45 |
 |
Revised |
|
2026-09-16 17:40 |
 |
Publication Fee Transferred |
|
|
 |
Editorial Processing by Scientific Editor |
|
2026-11-19 07:10 |
 |
Final Academic Decision by Editor-in-Chief |
|
|
 |
Publication Technical Verification by Editorial Office Director |
|
2026-11-19 12:17 |
 |
Articles in Press |
|
2026-11-19 12:17 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
|
| ISSN |
2219-2808 (online) |
| Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/ |
| Copyright |
©Author(s) (or their employer(s)) 2026. No commercial re-use. See Permissions. Published by Baishideng Publishing Group Inc. |
| Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
| Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
| Website |
http://www.wjgnet.com |
Copyright © 1993-2026 Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA. All rights reserved, including rights relating to text and data mining, AI training, and similar technologies. For open-access content, the applicable copyright and licensing terms govern.